Cargando…
Identification of potential biomarkers for lung adenocarcinoma
Lung adenocarcinoma (LUAD) is the most predominant subtype of lung cancers and is one of the leading causes of cancer related mortality worldwide. Despite the advancements in the field of cancer diagnostics and therapeutics, detection at an early stage using reliable biomarkers is an unmet clinical...
Autores principales: | Sayeeram, Deepak, Katte, Teesta V., Bhatia, Saloni, Jai Kumar, Anushree, Kumar, Avinesh, Jayashree, G., Rachana, D.S., Nalla Reddy, Harsha Vardhan, Arvind Rasalkar, Avinash, Malempati, Rajya Lakshmi, Reddy S, Divijendra Natha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677689/ https://www.ncbi.nlm.nih.gov/pubmed/33251353 http://dx.doi.org/10.1016/j.heliyon.2020.e05452 |
Ejemplares similares
-
COVID-19 and its impact on cancer, HIV, and mentally ill patients
por: Rasalkar, Avinash Arvind, et al.
Publicado: (2022) -
Assessing the Vulnerability
of Cancer Patients for
COVID-19
por: Bhatia, Saloni, et al.
Publicado: (2022) -
Transcriptomic landscape of breast cancers through mRNA sequencing
por: Eswaran, Jeyanthy, et al.
Publicado: (2012) -
Novel Insights into Breast Cancer Genetic Variance through RNA Sequencing
por: Horvath, Anelia, et al.
Publicado: (2013) -
A case of Acute myeloid leukemia complicated by post COVID-19 multi-system inflammatory syndrome-children
por: Reddy, Nalla Anuraag, et al.
Publicado: (2022)